Cargando…
The Potentially Therapeutic Role of EPAC in Curbing the Process of Idiopathic Pulmonary Fibrosis via Differential Cellular Pathways
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrosis disease caused by genetic susceptibility (causative) and other indirect risk factors such as smoking, micro-aspiration and air pollution. Repeated damage of lung epithelial cells can cause fibroblast activation and excessive colla...
Autores principales: | Cao, Xinwei, Li, Yajun, Shi, Jianrong, Tang, Huifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926039/ https://www.ncbi.nlm.nih.gov/pubmed/33679138 http://dx.doi.org/10.2147/JIR.S296382 |
Ejemplares similares
-
Identification of EPAC (Exchange Protein Activated by cAMP) bioinformatically as a potential signalling biomarker in Cardiovascular Disease (CVD) and its molecular docking by a lead molecule
por: Bala, Saranya, et al.
Publicado: (2011) -
“Denervation” of autonomous nervous system in idiopathic pulmonary arterial hypertension by low-dose radiation: a case report with an unexpected outcome
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2014) -
Nintedanib Inhibits Endothelial Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis via Focal Adhesion Kinase Activity Reduction
por: Yu, Wen-Kuang, et al.
Publicado: (2022) -
Comparison of CURB-65, PSI, and qSOFA for predicting pneumonia mortality in patients with idiopathic pulmonary fibrosis
por: Yamazaki, Ryo, et al.
Publicado: (2021) -
Decoding the differential biomarkers of Rheumatoid arthritis and Osteoarthritis: A functional genomics paradigm to design disease specific therapeutics
por: Biswas, Sreyasi, et al.
Publicado: (2011)